BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16443563)

  • 1. Blood pressure control in patients with hypertension: a community-based study.
    Wang L; Wei T
    Clin Exp Hypertens; 2006 Jan; 28(1):41-6. PubMed ID: 16443563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of isolated uncontrolled systolic blood pressure among treated hypertensive patients in primary care in Belgium: results of the I-inSYST survey.
    Van der Niepen P; Giot C; van de Borne P
    J Hypertens; 2008 Oct; 26(10):2057-63. PubMed ID: 18806631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study.
    Akram J; Sheikh UE; Mahmood M; Donnelly R
    Curr Med Res Opin; 2007 Dec; 23(12):2929-36. PubMed ID: 17931463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure control in treated hypertensive patients: clinical performance of general practitioners.
    Frijling BD; Spies TH; Lobo CM; Hulscher ME; van Drenth BB; Braspenning JC; Prins A; van der Wouden JC; Grol RP
    Br J Gen Pract; 2001 Jan; 51(462):9-14. PubMed ID: 11271892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regular alcohol drinking is a determinant of masked morning hypertension detected by home blood pressure monitoring in medicated hypertensive patients with well-controlled clinic blood pressure: the Jichi Morning Hypertension Research (J-MORE) study.
    Ishikawa J; Kario K; Eguchi K; Morinari M; Hoshide S; Ishikawa S; Shimada K;
    Hypertens Res; 2006 Sep; 29(9):679-86. PubMed ID: 17249523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
    Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I
    Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparison of the management of severe high blood pressure between 1999 and 2003 in France].
    Bertin N; Salanave B; Tilly B; Guilhot J; Ricordeau P; Fender P; Dematons MN; Treppoz H; Allemand H
    Arch Mal Coeur Vaiss; 2004; 97(7-8):793-8. PubMed ID: 15506068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
    Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
    Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High blood pressure despite treatment: results from a cross-sectional primary healthcare-based study in southern Sweden.
    Hedblad B; Nerbrand C; Ekesbo R; Johansson L; Midlöv P; Brunkstedt I; Svensson P; Gyllerup S; Sträng B; Persson R; Janzon L
    Scand J Prim Health Care; 2006 Dec; 24(4):224-30. PubMed ID: 17118862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional small amounts of diuretics improve blood pressure control at low cost without disadvantages in blood sugar metabolism.
    Kudoh T; Nagawaga T; Nakagawa I
    Hypertens Res; 2008 Mar; 31(3):455-62. PubMed ID: 18497464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and determinants of undertreatment of hypertension in the Netherlands.
    Schelleman H; Klungel OH; Kromhout D; de Boer A; Stricker BH; Verschuren WM
    J Hum Hypertens; 2004 May; 18(5):317-24. PubMed ID: 15103311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
    Guo QH; Pan CY; Qi WH; Lin SY;
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension management in patients with stable coronary disease].
    Amar J; Genès N; Vaur L; Charpentier G; Cambou JP; Guéret P
    Arch Mal Coeur Vaiss; 2002; 95(7-8):657-60. PubMed ID: 12365075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systolic vs diastolic blood pressure: community burden and impact on blood pressure staging.
    Banegas JR; de la Cruz JJ; Rodríguez-Artalejo F; Graciani A; Guallar-Castillón P; Herruzo R
    J Hum Hypertens; 2002 Mar; 16(3):163-7. PubMed ID: 11896505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.